Oztek-Celebi Fatma Z, Ozlu Sare G, Aydog Ozlem
Department of Paediatrics and Adolescent Medicine, Dr. Sami Ulus Obstetrics and Gynaecology and Paediatrics Training and Research Hospital, Ankara, Turkey.
Department of Paediatric Nephrology, Dr. Sami Ulus Obstetrics and Gynaecology and Paediatrics Training and Research Hospital, Ankara, Turkey.
Nephrology (Carlton). 2019 Feb;24(2):181-187. doi: 10.1111/nep.13248.
Acute kidney injury (AKI) is an important clinical condition that is associated with increased mortality and morbidity. This study was performed to identify the factors that influence AKI stage, undergoing renal replacement therapy (RRT) and mortality.
This study was retrospectively conducted on 219 children with AKI who had been referred to the paediatric nephrology division of Dr Sami Ulus Teaching Hospital during their inpatient treatment from 2008 to 2012. AKI was defined using pRIFLE criteria.
From the 219 enrolled patients, 131 were identified as having AKI at the time of hospital admission. Infant age group was the largest group. RRT was performed in 68 patients. Median RRT initiation time was 1.5 day (0-2) and the mortality increased significantly when RRT initiation time was >1 day. The likelihood of undergoing RRT was higher for patients who were younger, who were managed in PICU and who had intrinsic type of AKI. pRIFLE stage and AKI place did not influence the likelihood of undergoing RRT. Overall mortality was 26.9%. In log-rank tests, factors influencing survival were younger age, being treated in PICU, developing AKI during inpatient treatment, having a comorbid condition and undergoing RRT. pRIFLE stage did not influence survival. In the logistic regression model, factors associated with mortality included younger age, undergoing RRT and having AKI during inpatient treatment. Having underlying disease and being managed in PICU did not influence the likelihood of death.
Acute kidney injury is an important condition in all hospitalized patients. More studies and interventions are needed on this topic to identify, treat and prevent AKI.
急性肾损伤(AKI)是一种重要的临床病症,与死亡率和发病率的增加相关。本研究旨在确定影响AKI分期、接受肾脏替代治疗(RRT)及死亡率的因素。
本研究对2008年至2012年住院期间转诊至萨米·乌卢斯教学医院儿科肾病科的219例AKI患儿进行了回顾性研究。AKI采用pRIFLE标准进行定义。
在219例入组患者中,131例在入院时被确诊为AKI。婴儿年龄组是最大的群体。68例患者接受了RRT。RRT开始的中位时间为1.5天(0 - 2天),当RRT开始时间>1天时,死亡率显著增加。年龄较小、在儿科重症监护病房(PICU)接受治疗以及患有内在型AKI的患者接受RRT的可能性更高。pRIFLE分期和AKI发生部位不影响接受RRT的可能性。总体死亡率为26.9%。在对数秩检验中,影响生存的因素包括年龄较小、在PICU接受治疗、住院期间发生AKI、患有合并症以及接受RRT。pRIFLE分期不影响生存。在逻辑回归模型中,与死亡率相关的因素包括年龄较小、接受RRT以及住院期间发生AKI。患有基础疾病和在PICU接受治疗不影响死亡的可能性。
急性肾损伤在所有住院患者中都是一种重要病症。关于该主题需要更多研究和干预措施来识别、治疗和预防AKI。